Gauging the Odds (and the Costs) in Health Screening
1 hour 17 minutes ago To begin, it's important to understand that patients who aren't at high risk for cancer might have several reasons to choose against being screened for it. ...
* Celgene's cancer drug Revlimid meets goal of CALGB trial
Dec 18, 2009 08:33:53 The latest study was led by the Cancer and Leukemia Group B (CALGB). The group's independent data and safety monitoring board reported the trial had met its ...
Arthur Cores, co-founder of Boston Market chain, dies at 52
1 hour 33 minutes ago He was diagnosed with advanced cancer at age 45 and given only months to live. In 1985, while attending Northeastern University, he partnered with a friend ...